What is Thermo Fisher Scientific's AOCI?

Thermo Fisher Scientific (TMO) reported AOCI of -$2.5B in Q1 2026.

How has Thermo Fisher Scientific's AOCI changed year-over-year?

Thermo Fisher Scientific's AOCI decreased by 6.6% year-over-year, from -$2.34B to -$2.5B.

What is the long-term trend for Thermo Fisher Scientific's AOCI?

Over 5 years (2020 to 2025), Thermo Fisher Scientific's AOCI has grown at a -2.7% compound annual growth rate (CAGR), from -$2.81B to -$2.45B.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Thermo Fisher Scientific TMO AOCI

AOCI at other companies

Becton, Dickinson and CompanyBDX

-$1.76B-2.8%

Bio-Rad LaboratoriesBIO

-$235.4M+42.6%

GLW

CorningGLW

-$2.32B-20.0%

RevvityRVTY

-$253.56M+19.9%

Kewaunee Scientific CorporationKEQU

-$4.61M-21.3%

DanaherDHR

-$795M-39.7%

Other financials

Income statement

See full

Revenue$12.0B—

Operating income$2.1B—

Net income$1.7B+7.4%

EPS (diluted)$4.68+9.3%

Balance sheet

See full

Cash & equivalents$4.1B-11.7%

Total debt$39.2B+4.6%

Total equity$52.7B+4.3%

Total assets$113.17B+11.8%

Cash flow

See full

Operating cash flow$2.1B+51.9%

CapEx-$1.2B-509%

Free cash flow$923.0M-16.5%

Valuation

See full

Market cap$214.21B+17.7%

Enterprise value$249.32B+16.0%

P/E30.8×+3.1×

P/S4.8×-0.9×

Profitability

See full

Gross margin58.3%—

Operating margin17.2%+0.8pp

Net margin15.2%+1.0pp

FCF margin15.7%-2.1pp

Returns & leverage

See full

Return on equity13.5%+0.1pp

Debt / equity0.7×0.0×

Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Thermo Fisher Scientific's AOCI?: Thermo Fisher Scientific (TMO) reported AOCI of -$2.5B in Q1 2026.
How has Thermo Fisher Scientific's AOCI changed year-over-year?: Thermo Fisher Scientific's AOCI decreased by 6.6% year-over-year, from -$2.34B to -$2.5B.
What is the long-term trend for Thermo Fisher Scientific's AOCI?: Over 5 years (2020 to 2025), Thermo Fisher Scientific's AOCI has grown at a -2.7% compound annual growth rate (CAGR), from -$2.81B to -$2.45B.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.